• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1-(2-氯乙基)-3-烷基-3-(甲基氨基甲酰基)三氮烯的氧化代谢:氯乙醛的形成及其与生物活性的关系

Oxidative metabolism of 1-(2-chloroethyl)-3-alkyl-3- (methylcarbamoyl)triazenes: formation of chloroacetaldehyde and relevance to biological activity.

作者信息

Rouzer C A, Sabourin M, Skinner T L, Thompson E J, Wood T O, Chmurny G N, Klose J R, Roman J M, Smith R H, Michejda C J

机构信息

Department of Chemistry, Western Maryland College, Westminster 21157, USA.

出版信息

Chem Res Toxicol. 1996 Jan-Feb;9(1):172-8. doi: 10.1021/tx9500639.

DOI:10.1021/tx9500639
PMID:8924588
Abstract

(Methylcarbamoyl)triazenes have been shown to be effective cancer chemotherapeutic agents in a number of biological systems. Because of their chemical stability, it is likely that their activity in vivo is the result of a metabolic activation process. Previous studies have shown that 1-(2-chloroethyl)-3-methyl-3-(methylcarbamoyl)triazene (CMM) and 1-(2-chloroethyl)-3-benzyl-3-(methylcarbamoyl)triazene (CBzM) are metabolized by rat liver microsomes in the presence of NADPH to yield the ((hydroxymethyl)carbamoyl)triazene analogs of the parent compounds. The present studies show that both compounds are also oxidized at the chloroethyl substituent to yield chloroacetaldehyde and a substituted urea. In the case of CBzM metabolism, 47% of the metabolized parent compound was recovered as benzylmethylurea, 8% was recovered as benzylurea, and 26% was recovered as the ((hydroxymethyl)carbamoyl)-triazene and carbamoyltriazene metabolites. These results suggest that the chloroethyl group is the favored initial site of metabolism. In reaction mixtures containing initial concentrations of 300 microM CBzM, 78 microM chloroacetaldehyde was produced, as compared to 58 microM chloroacetaldehyde produced from the metabolism of 300 microM CMM. The formation of chloroacetaldehyde, a known mutagenic DNA alkylating agent, may explain the biological activity of these compounds.

摘要

(甲基氨基甲酰基)三氮烯已被证明在许多生物系统中是有效的癌症化疗药物。由于它们的化学稳定性,其体内活性很可能是代谢活化过程的结果。先前的研究表明,1-(2-氯乙基)-3-甲基-3-(甲基氨基甲酰基)三氮烯(CMM)和1-(2-氯乙基)-3-苄基-3-(甲基氨基甲酰基)三氮烯(CBzM)在NADPH存在下被大鼠肝脏微粒体代谢,生成母体化合物的((羟甲基)氨基甲酰基)三氮烯类似物。目前的研究表明,这两种化合物在氯乙基取代基处也会被氧化,生成氯乙醛和一种取代脲。就CBzM的代谢而言,47%的代谢母体化合物以苄基甲基脲的形式回收,8%以苄基脲的形式回收,26%以((羟甲基)氨基甲酰基)三氮烯和氨基甲酰基三氮烯代谢物的形式回收。这些结果表明氯乙基是代谢的首选初始位点。在含有初始浓度为300 microM CBzM的反应混合物中,产生了78 microM氯乙醛,相比之下,由300 microM CMM代谢产生的氯乙醛为58 microM。氯乙醛是一种已知的诱变DNA烷基化剂,其形成可能解释了这些化合物的生物活性。

相似文献

1
Oxidative metabolism of 1-(2-chloroethyl)-3-alkyl-3- (methylcarbamoyl)triazenes: formation of chloroacetaldehyde and relevance to biological activity.1-(2-氯乙基)-3-烷基-3-(甲基氨基甲酰基)三氮烯的氧化代谢:氯乙醛的形成及其与生物活性的关系
Chem Res Toxicol. 1996 Jan-Feb;9(1):172-8. doi: 10.1021/tx9500639.
2
An unexpected pathway for the metabolic degradation of 1,3-dialkyl-3-acyltriazenes.
Biochem Pharmacol. 1993 Jul 6;46(1):165-73. doi: 10.1016/0006-2952(93)90361-y.
3
NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.国家毒理学计划关于水合氯醛(化学物质登记号:302-17-0)毒性和代谢研究的技术报告。通过灌胃法给予F344/N大鼠和B6C3F1小鼠。
Toxic Rep Ser. 1999 Aug(59):1-66, A1-E7.
4
High-performance liquid chromatographic-fluorescent method to determine chloroacetaldehyde, a neurotoxic metabolite of the anticancer drug ifosfamide, in plasma and in liver microsomal incubations.
Anal Biochem. 1999 Aug 15;273(1):117-25. doi: 10.1006/abio.1999.4197.
5
Specificity of DNA alkylation by 1-(2-chloroethyl)-3-alkyl-3-acyltriazenes depends on the structure of the acyl group: kinetic and product studies.1-(2-氯乙基)-3-烷基-3-酰基三氮烯对DNA的烷基化特异性取决于酰基结构:动力学和产物研究
Chem Res Toxicol. 1996 Mar;9(2):466-75. doi: 10.1021/tx950155y.
6
Human liver microsomal reduction of pyrrolizidine alkaloid N-oxides to form the corresponding carcinogenic parent alkaloid.人肝微粒体将吡咯里西啶生物碱氮氧化物还原为相应的致癌母体生物碱。
Toxicol Lett. 2005 Mar 15;155(3):411-20. doi: 10.1016/j.toxlet.2004.11.010.
7
NTP Technical Report on the metabolism, toxicity and predicted carcinogenicity of diazoaminobenzene (CAS No. 136-35-6).美国国家毒理学计划关于重氮氨基苯(化学物质登记号:136-35-6)的代谢、毒性及预测致癌性的技术报告
Toxic Rep Ser. 2002 Sep(73):1-23, A1-C6.
8
Microsomal metabolism of triazenylimidazoles.
Cancer Res. 1975 Nov;35(11 Pt 1):3106-10.
9
Toxicity of ifosfamide and its metabolite chloroacetaldehyde in cultured renal tubule cells.异环磷酰胺及其代谢产物氯乙醛对培养肾小管细胞的毒性作用。
In Vitro Cell Dev Biol Anim. 1999 Jun;35(6):314-7. doi: 10.1007/s11626-999-0080-y.
10
New ifosfamide analogs designed for lower associated neurotoxicity and nephrotoxicity with modified alkylating kinetics leading to enhanced in vitro anticancer activity.新的异环磷酰胺类似物,旨在降低相关神经毒性和肾毒性,具有经修饰的烷基化动力学,从而增强体外抗癌活性。
J Pharmacol Exp Ther. 2009 Feb;328(2):598-609. doi: 10.1124/jpet.108.144170. Epub 2008 Nov 18.

引用本文的文献

1
Syntheses and crystal structure of 4-[(pyridin-3-yl)diazen-yl]morpholine and 1-[(pyridin-3-yl)diazen-yl]-1,2,3,4-tetra-hydro-quinoline.4-[(吡啶-3-基)重氮基]吗啉和1-[(吡啶-3-基)重氮基]-1,2,3,4-四氢喹啉的合成与晶体结构
Acta Crystallogr E Crystallogr Commun. 2023 Jan 10;79(Pt 2):74-78. doi: 10.1107/S2056989023000129. eCollection 2023 Jan 1.
2
Crystal structure and spectroscopic properties of ()-1,3-dimethyl-2-[3-(4-nitro-phen-yl)triaz-2-enyl-idene]-2,3-di-hydro-1-imidazole.()-1,3-二甲基-2-[3-(4-硝基苯基)三氮烯-2-亚基]-2,3-二氢-1-咪唑的晶体结构和光谱性质
Acta Crystallogr E Crystallogr Commun. 2021 Jan 15;77(Pt 2):130-133. doi: 10.1107/S2056989021000426. eCollection 2021 Feb 1.
3
Crystal structure of (E)-1,3-dimethyl-2-[3-(3-nitro-phen-yl)triaz-2-en-1-yl-idene]-2,3-di-hydro-1H-imidazole.
(E)-1,3-二甲基-2-[3-(3-硝基苯基)三氮烯-2-亚基]-2,3-二氢-1H-咪唑的晶体结构
Acta Crystallogr Sect E Struct Rep Online. 2014 Sep 20;70(Pt 10):224-7. doi: 10.1107/S1600536814020698. eCollection 2014 Oct 1.